Dechra Veterinary Products markets key equine products including Osphos® (clodronate injection) which is an intramuscular bisphosphonate injection indicated for the clinical signs associated with navicular syndrome in horses. OSPHOS inhibits bone resorption by binding to calcium phosphate crystals (inhibiting their formation and dissolution) and by exerting direct cellular effects on osteoclasts. Our regenerative medicine portfolio includes Orthokine® vet irap 10mL and 60mL (ACS) devices and the Osteokine® Easy PRP Prep device. Dechra also sells Equidone® Gel (domperidone) for the prevention of fescue toxicosis in periparturient mares.
www.dechra-us.com
Shelly Derks, Equine Marketing Manager
Dechra Veterinary Products
7015 College Blvd, Ste 525
Overland Park, KS 66211
Bedford Hills, NY 10507
(913) 327-0015
shelly.derks@dechra.com
Deidre de Bruin, North Florida Sales Mgr-Equine
(727) 366-7462
diedre.debruin@dechra.com
Back to the Educational Partners page